Alani RM - Search Results

1

Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction.

Stine MJ, Wang CJ, Moriarty WF, Ryu B, Cheong R, Westra WH, Levchenko A, Alani RM. Stine MJ, et al. Among authors: alani rm. Cancer Res. 2011 Apr 1;71(7):2433-44. doi: 10.1158/0008-5472.CAN-10-1875. Epub 2011 Feb 15. Cancer Res. 2011. PMID: 21324919 Free PMC article.

2

Neuropilin-2: a novel biomarker for malignant melanoma?

Rushing EC, Stine MJ, Hahn SJ, Shea S, Eller MS, Naif A, Khanna S, Westra WH, Jungbluth AA, Busam KJ, Mahalingam M, Alani RM. Rushing EC, et al. Among authors: alani rm. Hum Pathol. 2012 Mar;43(3):381-9. doi: 10.1016/j.humpath.2011.05.008. Epub 2011 Aug 15. Hum Pathol. 2012. PMID: 21840568 Free PMC article.

3

Notch signaling mediates melanoma-endothelial cell communication and melanoma cell migration.

Howard JD, Moriarty WF, Park J, Riedy K, Panova IP, Chung CH, Suh KY, Levchenko A, Alani RM. Howard JD, et al. Among authors: alani rm. Pigment Cell Melanoma Res. 2013 Sep;26(5):697-707. doi: 10.1111/pcmr.12131. Epub 2013 Jul 19. Pigment Cell Melanoma Res. 2013. PMID: 23773728

4

Neuropilin-2 promotes melanoma growth and progression in vivo.

Moriarty WF, Kim E, Gerber SA, Hammers H, Alani RM. Moriarty WF, et al. Among authors: alani rm. Melanoma Res. 2016 Aug;26(4):321-8. doi: 10.1097/CMR.0000000000000190. Melanoma Res. 2016. PMID: 26881875

5

Id proteins in cell growth and tumorigenesis.

Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Sikder HA, et al. Among authors: alani rm. Cancer Cell. 2003 Jun;3(6):525-30. doi: 10.1016/s1535-6108(03)00141-7. Cancer Cell. 2003. PMID: 12842081 Free article. Review.

6

Id1 expression is transcriptionally regulated in radial growth phase melanomas.

Ryu B, Kim DS, DeLuca AM, Healey MA, Dunlap S, Fackler MJ, Herman J, Alani RM. Ryu B, et al. Among authors: alani rm. Int J Cancer. 2007 Oct 15;121(8):1705-9. doi: 10.1002/ijc.22875. Int J Cancer. 2007. PMID: 17565736 Free article.

7

Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.

Ryu B, Kim DS, Deluca AM, Alani RM. Ryu B, et al. Among authors: alani rm. PLoS One. 2007 Jul 4;2(7):e594. doi: 10.1371/journal.pone.0000594. PLoS One. 2007. PMID: 17611626 Free PMC article.

8

MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.

Kim E, Zucconi BE, Wu M, Nocco SE, Meyers DJ, McGee JS, Venkatesh S, Cohen DL, Gonzalez EC, Ryu B, Cole PA, Alani RM. Kim E, et al. Among authors: alani rm. Cancer Res. 2019 May 15;79(10):2649-2661. doi: 10.1158/0008-5472.CAN-18-2331. Epub 2019 Mar 25. Cancer Res. 2019. PMID: 30910803 Free PMC article.

9

Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors.

Sikder H, Huso DL, Zhang H, Wang B, Ryu B, Hwang ST, Powell JD, Alani RM. Sikder H, et al. Among authors: alani rm. Cancer Cell. 2003 Oct;4(4):291-9. doi: 10.1016/s1535-6108(03)00245-9. Cancer Cell. 2003. PMID: 14585356 Free article.

10

Id1 delays senescence of primary human melanocytes.

Cummings SD, Ryu B, Samuels MA, Yu X, Meeker AK, Healey MA, Alani RM. Cummings SD, et al. Among authors: alani rm. Mol Carcinog. 2008 Sep;47(9):653-9. doi: 10.1002/mc.20422. Mol Carcinog. 2008. PMID: 18240291 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page